These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1906451)

  • 1. Novel and potent gastrin and brain cholecystokinin antagonists from Streptomyces olivaceus. Taxonomy, fermentation, isolation, chemical conversions, and physico-chemical and biochemical properties.
    Lam YK; Bogen D; Chang RS; Faust KA; Hensens OD; Zink DL; Schwartz CD; Zitano L; Garrity GM; Gagliardi MM
    J Antibiot (Tokyo); 1991 Jun; 44(6):613-25. PubMed ID: 1906451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New virginiamycin M1 derivatives: synthesis, cholecystokinin binding inhibitory and antimicrobial properties.
    Lam YK; Dai P; Zink DL; Smith AJ; Lee NW; Freedman S; Salvatore MJ
    J Antibiot (Tokyo); 1993 Apr; 46(4):623-30. PubMed ID: 8501005
    [No Abstract]   [Full Text] [Related]  

  • 3. Characterization of the binding of [3H]L-365,260: a new potent and selective brain cholecystokinin (CCK-B) and gastrin receptor antagonist radioligand.
    Chang RS; Chen TB; Bock MG; Freidinger RM; Chen R; Rosegay A; Lotti VJ
    Mol Pharmacol; 1989 Jun; 35(6):803-8. PubMed ID: 2733696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benzodiazepine analogues L365,260 and L364,718 as gastrin and pancreatic CCK receptor antagonists.
    Huang SC; Zhang L; Chiang HC; Wank SA; Maton PN; Gardner JD; Jensen RT
    Am J Physiol; 1989 Jul; 257(1 Pt 1):G169-74. PubMed ID: 2473653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365,260.
    Lotti VJ; Chang RS
    Eur J Pharmacol; 1989 Mar; 162(2):273-80. PubMed ID: 2721567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical and pharmacological characterization of an extremely potent and selective nonpeptide cholecystokinin antagonist.
    Chang RS; Lotti VJ
    Proc Natl Acad Sci U S A; 1986 Jul; 83(13):4923-6. PubMed ID: 3014520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholecystokinin antagonists. Synthesis and biological evaluation of 4-substituted 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepines.
    Bock MG; DiPardo RM; Evans BE; Rittle KE; Veber DF; Freidinger RM; Chang RS; Lotti VJ
    J Med Chem; 1988 Jan; 31(1):176-81. PubMed ID: 3336017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of antagonist of receptors for gastrin, cholecystokinin and bombesin on growth of gastroduodenal mucosa and pancreas.
    Dembiński A; Warzecha Z; Konturek SJ; Banas M; Cai RZ; Schally AV
    J Physiol Pharmacol; 1991 Sep; 42(3):263-77. PubMed ID: 1665365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the CCKB receptor antagonism of virginiamycin in guinea-pig ileum longitudinal myenteric plexus.
    Corsi M; Pojani G; Dal Forno G; Pietra C; Gaviraghi G; Trist D
    Br J Pharmacol; 1993 Apr; 108(4):1164-8. PubMed ID: 8485626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33).
    Lin CW; Holladay MW; Barrett RW; Wolfram CA; Miller TR; Witte D; Kerwin JF; Wagenaar F; Nadzan AM
    Mol Pharmacol; 1989 Dec; 36(6):881-6. PubMed ID: 2601685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Species specificity of pharmacological characteristics of CCK-B receptors.
    Kuwahara T; Kudoh T; Nakano A; Yoshizaki H; Takamiya M; Nagase H; Arisawa M
    Neurosci Lett; 1993 Aug; 158(1):1-4. PubMed ID: 8233061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Gastrin" and "CCK" receptors on histamine- and somatostatin-containing cells from rabbit fundic mucosa-II. Characterization by means of selective antagonists (L-364,718 and L-365,260).
    Roche S; Gusdinar T; Bali JP; Magous R
    Biochem Pharmacol; 1991 Jul; 42(4):771-6. PubMed ID: 1714276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of CCK receptors in a novel smooth muscle preparation from the guinea-pig stomach by use of the selective antagonists CI-988, L-365,260 and devazepide.
    Boyle SJ; Tang KW; Woodruff GN; McKnight AT
    Br J Pharmacol; 1993 Aug; 109(4):913-7. PubMed ID: 8401944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-antigastrin activity relationships of new spiroglumide amido acid derivatives.
    Makovec F; Peris W; Frigerio S; Giovanetti R; Letari O; Mennuni L; Revel L
    J Med Chem; 1996 Jan; 39(1):135-42. PubMed ID: 8568800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of antagonists of receptors for gastrin, cholecystokinin and bombesin on growth of gastroduodenal mucosa and pancreas.
    Dembiński A; Warzecha Z; Konturek SJ; Cai RZ; Schally AV
    J Physiol Pharmacol; 1991 Jun; 42(2):195-209. PubMed ID: 1664265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined dose-ratio analysis for the CCK-B antagonist virginiamycin in guinea pig ileum.
    Corsi M; Dal Forno G; Oliosi B; Pietra C; van Amsterdam FT; Trist DG
    Ann N Y Acad Sci; 1994 Mar; 713():353-4. PubMed ID: 8185185
    [No Abstract]   [Full Text] [Related]  

  • 17. Attenuation of gastrin-induced gastric acid secretion by antisense oligonucleotide to the CCKB/gastrin receptor.
    Rao RK; Lopez Y; Lai J; Riviere PJ; Junien JL; Porreca F
    Neuroreport; 1995 Nov; 6(17):2373-7. PubMed ID: 8747156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereospecific reduction of virginiamycin M1 as the virginiamycin resistance pathway in Streptomyces virginiae.
    Lee CK; Minami M; Sakuda S; Nihira T; Yamada Y
    Antimicrob Agents Chemother; 1996 Mar; 40(3):595-601. PubMed ID: 8851577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological properties of ureido-acetamides, new potent and selective non-peptide CCKB/gastrin receptor antagonists.
    Bertrand P; Böhme GA; Durieux C; Guyon C; Capet M; Jeantaud B; Boudeau P; Ducos B; Pendley CE; Martin GE
    Eur J Pharmacol; 1994 Sep; 262(3):233-45. PubMed ID: 7813588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of two novel cholecystokinin tetrapeptide (30-33) analogues, A-71623 and A-70874, that exhibit high potency and selectivity for cholecystokinin-A receptors.
    Lin CW; Shiosaki K; Miller TR; Witte DG; Bianchi BR; Wolfram CA; Kopecka H; Craig R; Wagenaar F; Nadzan AM
    Mol Pharmacol; 1991 Mar; 39(3):346-51. PubMed ID: 1706470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.